Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Sergio Giralt(Memorial Sloan Kettering Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Auro del Giglio(Faculdade de Medicina do ABC), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Mary Beth Rios(The University of Texas MD Anderson Cancer Center), Börje S. Andersson(The University of Texas MD Anderson Cancer Center), A B Deisseroth(The University of Texas MD Anderson Cancer Center), Moshe Talpaz(University of Michigan)
Cited by 84
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k